Clinical Trial

AutoSTEA for Adults With Functional Dyspepsia

Active, Not Recruiting Phase 1
View on ClinicalTrials.gov →
Record status
This record was last updated June 13, 2025 (before its estimated April 2026 completion). Its status may not reflect the trial's current state.
Summary
The goal of this study is to assess how effective the AutoSTEA device is in treating functional dyspepsia (upper abdominal discomfort) in adults. It will also assess the safety and usability of the device. The main questions it aims to answer are: * Does the AutoSTEA device ease dyspepsia symptoms? * Is the AutoSTEA device safe and feasible for patients to use at their home? Participants will: * Use the device for half an hour every day for two weeks * Have a phone check-in halfway through the trial * Answer the daily and weekly questionnaires which consist of questions regarding symptoms, device usability, and adverse events experienced.
Trial Details
NCT Number NCT07020416
Lead Sponsor MetroHealth Medical Center
Conditions Functional Dyspepsia
Enrollment 20 participants
Start Date 2025-02-26
Primary Completion 2026-04 (estimated)
Study Completion 2027-02 (estimated)
Updated on ClinicalTrials.gov 2025-06-13